Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
Open Access
- 25 February 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 162 (4) , 468-473
- https://doi.org/10.1001/archinte.162.4.468
Abstract
CORONARY ARTERY disease (CAD) is a leading cause of mortality in the United States, responsible for a half million deaths in 1996 and contributing to substantial morbidity.1 For 1999, it was estimated that 1.1 million Americans would have a new (650 000 people) or recurrent (450 000 people) myocardial infarction (MI), with one third of those events resulting in a fatality.1Keywords
This publication has 1 reference indexed in Scilit: